Biotech · Private company · Rockport, MA, US
Daybreak Pharmaceuticals Inc
Track this companyFree. Adds Daybreak Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Enhancing Chemotherapy Efficacy by Targeting the Mutagenic Translesion Synthesis PathwayFiscal year 2026 · $303.3KNIH RePORTER 1R43CA310344-01 · fetched Nov 12, 2026